Ridaforolimus Eluting Coronary Stent System

  • Excellent clinical outcomes
  • Exceptionally deliverable
  • Integrated stent markers for clear visibility for post implantation
  • Low footprint cobalt-chromium design
  • Optimal conformability and vessel support
  • Elastomeric coating for outstanding surface integrity

For specific country information please contact Medinol.

 

For more information about the product:

EluNIR-PERL First-In-Patient Implantation

Prof. Haim Danenberg, MD

First implantation of the EluNIR-PERL elastomeric Drug Eluting Stent, the only DES with two radiopaque markers at each end of the stent.

Enhanced Flexx²

  • Polymer covered distal tip for reduced friction to enter even the tightest lesions
  • A tapered spring tip designed to closely track the guidewire and eliminate flare-out and buckling common to plastic tips
  • The only radiopaque tip on the market, enabling visualization of the catheter-tip location during procedure
  • Reinforced hypotube for better hub-to-tip force transfer, enabling to navigate through tortuous anatomy without kinking

Designed for superior deliverability and crossability

Superior crossability of difficult lesions, calcifications and implanted stent

Tip Visibility – The only radiopaque tip

Stent Length
mm8121517202428333844
2.25ELM225R08INELM225R12INELM225R15IN ELM225R17INELM225R20INELM225R24INELM225R28INELM225R33IN
2.5ELM250R08INELM250R12INELM250R15INELM250R17INELM250R20INELM250R24INELM250R28INELM250R33IN
2.75ELM275R08INELM275R12INELM275R15INELM275R17INELM275R20INELM275R24INELM275R28INELM275R33INELM275R38INELM275R44IN
3.0ELM300R08INELM300R12INELM300R15INELM300R17INELM300R20INELM300R24INELM300R28INELM300R33INELM300R38INELM300R44IN
3.5ELM350R08INELM350R12INELM350R15INELM350R17INELM350R20INELM350R24INELM350R28INELM350R33INELM350R38INELM350R44IN
4.0ELM400R08INELM400R12INELM400R15INELM400R17INELM400R20INELM400R24INELM400R28INELM400R33INELM400R38INELM400R44IN

Enhanced Flexx²

  • Polymer covered distal tip for reduced friction to enter even the tightest lesions
  • A tapered spring tip designed to closely track the guidewire and eliminate flare-out and buckling common to plastic tips
  • The only radiopaque tip on the market, enabling visualization of the catheter-tip location during procedure
  • Reinforced hypotube for better hub-to-tip force transfer, enabling to navigate through tortuous anatomy without kinking

Designed for superior deliverability and crossability

Superior crossability of difficult lesions, calcifications and implanted stent

Tip Visibility – The only radiopaque tip

WiZeCell
Stent Design

  • Low footprint cobalt-chromium design with ultra-narrow 40µm struts
  • Best In Class Scaffolding: adaptive cell size designed for optimal scaffolding and uniform drug dosing while preventing tissue prolapse
  • Excellent conformability in curved sections even during myocardial contractions
  • Low crossing profile and flexibility for improved deliverability
  • Optimized side branch access

Low footprint variable width design

40µm ultra narrow struts provides flexibility and conformability

Optimal scaffolding area provides uniform support and drug elution and prevents tissue prolapse

72µm struts provides excellent radial strength

Natural vessel curvature and myocardial contractions test the limits of stent design and scaffolding integrity.
EluNIR’s optimized cell size ensures uniform scaffolding and prevents tissue prolapse and strut overlap.

EluNIR

Competitor A

Competitor B

Competitor C

 

Note how other stents enable large openings, contributing to tissue prolapse and potentially restenosis.

 

eDES Coating

  • The first and only elastomeric* Drug Eluting Stent (eDES™)
  • exceptional surface quality
  • long term coating integrity
  • Comprehensive and controlled drug elution

*Elastomer – high elasticity polymer

  • Medinol purposefully designed EluNIR’s coating for high performance and endurance.
  • EluNIR’s elastomeric coating maintains long-term surface integrity and enables predictable, uniform release of a limus drug to the vessel wall.
  • Improved surface quality and long term coating integrity may promote clinical advantages such as more uniform drug elution, better endothelialization, lower inflammation, lower ST and restenosis rates.

Images of EluNIR before and after drug elution. Notice the coating quality:

Elastomeric Coating

Crimped

Expanded

After Elution

  • Polymer coatings of other drug eluting stents often present surface deformations, webbing, cracking and peeling
  • These surface imperfections were associated with inflammation and thrombogenicity and may also result in non-uniform drug release1

Images of commercially available drug eluting stents before and after drug elution. Notice the damaged coating:

1 Basalus et al., Eurointervention 2013; 9:302-305

Watch Dr. Kobi Richter, Founder and CTO of Medinol, in how EluNIR is coated

Stent Visibility

  • 2 radiopaque markers integrated at each end of the stent for during & post-implantation visibility
  • Easily visualize stent boarders for recrossing and side branch access.

Post Implantation

Integrated Radiopaque Markers

Integrated Radiopaque Markers